Therapy Areas: Diabetes
Afimmune Initiates Epeleuton Phase IIb TRIAGE Study in Patients with High Triglycerides and Type 2 Diabetes
23 September 2020 - - Dublin-based clinical stage drug discovery company Afimmune has started TRIAGE (TRIglyceride And Glucose control with Epeleuton in Metabolic Syndrome Patients...
Change Healthcare Aims to Bring More COVID-19 Testing Options to Consumers by Simplifying Billing
23 September 2020 - - US-based healthcare technology company Change Healthcare (NASDAQ: CHNG) has launched a new solution that makes it easier for consumers to get COVID-19 testing in their local phar...
Sotorasib Shows Promising Results in Some Patients with Solid Tumors, Suggests a Study With city of Hope as a Co-Lead Author
21 September 2020 - - A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorecta...
Algiax Pharmaceuticals Announces First Patient Enrolled in Phase IIa Multi-center Proof-of-Concept Study Evaluating AP-325 in Chronic Neuropathic Pain
21 September 2020 - - The first patient has been enrolled in the "CURE" study, Germany-based biotechnology company Algiax Pharmaceuticals, a clinical-stage biotechnology company focused on d...
Study Finds That Children's Immune Response Protects Against COVID-19
21 September 2020 - - The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have mi...
Celltrion Receives Korean MFDS Approval to Initiate Phase II/III Pivotal Trial of an Anti-COVID-19 Monoclonal Antibody Treatment Candidate, CT-P59
17 September 2020 - - The Korean Ministry of Food and Drug Safety has approved South Korea-based Celltrion Group's Investigational New Drug application for a Phase II/III pivotal clinical trial o...